Glory Holdings announced on November 27 that hainan huluwa pharmaceutical group (605199.SH) received a notice from Zhongjiao Rui stating that the shareholding plan had been completed. From November 25 to November 26, 2024, Zhongjiao Rui reduced its shareholding by a total of 5,341,050 shares, accounting for 1.33% of the company's total share capital.
葫芦娃(605199.SH):中嘉瑞累计减持1.33%股份
Hainan Huluwa Pharmaceutical Group (605199.SH): Zhongjia Rui has cumulatively reduced its shareholding by 1.33%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.